AORT

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Artivion Inc

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
CEO
James Mackin
Employees
1200
Headquarters

1655 Roberts Blvd NW
Kennesaw, Georgia 30144-3632
Phone: 17704193355
www.cryolife.com

News

Artivion SVP Sold $124K In Company Stock
Aug 11, 2022 14:33pm

Dennis B Maier , SVP at Artivion (NYSE: AORT ), reported a large insider sell on August 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Maier sold 5,762 shares of Artivion . The total transaction amounted to $124,512. Artivion shares are trading up 0.37% at $21.98 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make an … Full story available on Benzinga.com


Source:Benzinga
Artivion, Inc. (AORT) CEO James Mackin on Q2 2022 Results - Earnings Call Transcript
Aug 07, 2022 05:18am

Artivion, Inc. (NYSE:NYSE:AORT) Q2 2022 Earnings Conference Call August 04, 2022, 16:30 ET Company Participants Brian Johnston - Gilmartin Group James Mackin - Chairman, President & CEO…


Source:Seeking Alpha
Artivion Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $80.34M beats by $3.07M
Aug 04, 2022 21:10pm

Artivion press release (AORT): Q2 Non-GAAP EPS of -$0.03 misses by $0.06.Revenue of $80.34M (+5.5% Y/Y) beats by $3.07M.The company continues to expect constant currency revenue…


Source:Seeking Alpha
Artivion to Participate in Upcoming Investor Conferences
Aug 03, 2022 12:25pm

ATLANTA, Aug. 3, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. Artivion''s management team will present at the upcoming Canaccord…


Source:PR Newswire